ASCP Proudly Supports the Sickle Cell Disease Comprehensive Care Act

• ASCP joined more than 75 organizations in urging Congress to enact the bipartisan Sickle Cell Disease Comprehensive Care Act, which would expand access to coordinated, high‑quality Medicaid care for people living with sickle cell disease. 

• The Society remains a strong advocate of the SCDCCA. 

ASCP recently amplified the collective call for Congressional action by signing a letter urging the Senate Finance Committee and House Energy and Commerce Health Subcommittee to include the Sickle Cell Disease Comprehensive Care Act (SCDCCA)  (S. 721 / H.R. 5178) in an upcoming hearing or markup. ASCP and more than75 groups in signing the letter.  

The SCDCCA is bipartisan legislation that aims to ensure that individuals with sickle cell disease (SCD) have better access to coordinated, high-quality outpatient care – including all recommended clinical, mental health, ancillary, and support services – by allowing states to establish Medicaid Health Home programs with SCD as the single qualifying condition for eligibility.  

ASCP has strongly supported this legislation since first approached about it by the American Society of Hematology, and we will continue to advocate for its passage while keeping members informed as it progresses.